Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21640651 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
Condition: Aneurysmal Subarachnoid Hemorrhage
Interventions: Drug: clazosentan;   Drug: placebo

Indicates status has not been verified in more than two years